289 related articles for article (PubMed ID: 18003766)
21. Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention.
Gurm HS; Smith DE; Berwanger O; Share D; Schreiber T; Moscucci M; Nallamothu BK;
JACC Cardiovasc Interv; 2012 Jan; 5(1):98-104. PubMed ID: 22230155
[TBL] [Abstract][Full Text] [Related]
22. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.
Nallamothu BK; Shojania KG; Saint S; Hofer TP; Humes HD; Moscucci M; Bates ER
Am J Med; 2004 Dec; 117(12):938-47. PubMed ID: 15629733
[TBL] [Abstract][Full Text] [Related]
23. [Use of N-acetylcysteine prior to cardiac catheterization to prevent acute renal injury in patients with stage III chronic kidney disease].
Shavit L; Lifschitz M; Lachish T; Rosenmann D; Balkin J; Slotki I
Harefuah; 2007 Sep; 146(9):655-9, 736. PubMed ID: 17969299
[TBL] [Abstract][Full Text] [Related]
24. Contrast-induced nephropathy: what are the true clinical consequences?
Rudnick M; Feldman H
Clin J Am Soc Nephrol; 2008 Jan; 3(1):263-72. PubMed ID: 18178787
[TBL] [Abstract][Full Text] [Related]
25. [Nephropathy caused by radiocontrast media].
Kolarz M; Sułowicz W
Przegl Lek; 2005; 62(5):292-8. PubMed ID: 16334535
[TBL] [Abstract][Full Text] [Related]
26. Mitigating contrast-induced acute kidney injury associated with cardiac catheterization.
Nunag M; Brogan M; Garrick R
Cardiol Rev; 2009; 17(6):263-9. PubMed ID: 19829174
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
[TBL] [Abstract][Full Text] [Related]
28. Contrast-induced nephropathy.
McCullough PA; Soman SS
Crit Care Clin; 2005 Apr; 21(2):261-80. PubMed ID: 15781162
[TBL] [Abstract][Full Text] [Related]
29. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence.
Bagshaw SM; McAlister FA; Manns BJ; Ghali WA
Arch Intern Med; 2006 Jan; 166(2):161-6. PubMed ID: 16432083
[TBL] [Abstract][Full Text] [Related]
30. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
Asher I; Hammerman A; Sthoeger Z
Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
[TBL] [Abstract][Full Text] [Related]
31. Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?
Billinger M; Hess OM; Meier B
Eur Heart J; 2004 Feb; 25(3):188-9. PubMed ID: 14972417
[No Abstract] [Full Text] [Related]
32. Contrast nephropathy: review focusing on prevention.
Maeder M; Klein M; Fehr T; Rickli H
J Am Coll Cardiol; 2004 Nov; 44(9):1763-71. PubMed ID: 15519005
[TBL] [Abstract][Full Text] [Related]
33. Prevention of contrast-induced nephropathy with volume expansion.
Weisbord SD; Palevsky PM
Clin J Am Soc Nephrol; 2008 Jan; 3(1):273-80. PubMed ID: 17989201
[TBL] [Abstract][Full Text] [Related]
34. N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
Stenstrom DA; Muldoon LL; Armijo-Medina H; Watnick S; Doolittle ND; Kaufman JA; Peterson DR; Bubalo J; Neuwelt EA
J Vasc Interv Radiol; 2008 Mar; 19(3):309-18. PubMed ID: 18295688
[TBL] [Abstract][Full Text] [Related]
35. Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality?
Mehran R; Brar S; Dangas G
J Am Coll Cardiol; 2010 May; 55(20):2210-1. PubMed ID: 20466201
[No Abstract] [Full Text] [Related]
36. Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats.
Petronilho F; Constantino L; de Souza B; Reinke A; Martins MR; Fraga CM; Ritter C; Dal-Pizzol F
Nephrol Dial Transplant; 2009 Jul; 24(7):2077-82. PubMed ID: 19204016
[TBL] [Abstract][Full Text] [Related]
37. N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect.
Levin A; Pate GE; Shalansky S; Al-Shamari A; Webb JG; Buller CE; Humphries KH
Nephrol Dial Transplant; 2007 Sep; 22(9):2520-4. PubMed ID: 17557777
[TBL] [Abstract][Full Text] [Related]
38. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
Sisillo E; Ceriani R; Bortone F; Juliano G; Salvi L; Veglia F; Fiorentini C; Marenzi G
Crit Care Med; 2008 Jan; 36(1):81-6. PubMed ID: 18090169
[TBL] [Abstract][Full Text] [Related]
39. Prevention of contrast-induced nephropathy in patients undergoing emergent coronary procedures.
Bouzas-Mosquera A; Vázquez-Rodríguez JM
Am J Cardiol; 2008 Mar; 101(6):910. PubMed ID: 18328863
[No Abstract] [Full Text] [Related]
40. Prevention of intravenous contrast-induced nephropathy in hospital inpatients.
Kakkar R; Sobieszczyk P; Binkert CA; Faxon DP; Mortele KJ; Singh AK
Crit Pathw Cardiol; 2008 Mar; 7(1):1-4. PubMed ID: 18458660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
